Changes in lipid, liver, and renal profiles among patients with severe covid-19 during and after hospitalization at Saint Peter Specialized Hospital, Addis Ababa
DOI:
https://doi.org/10.20372/ejphn.V8i1.251Keywords:
COVID-19, Lipid profile, Liver function test, Renal function testAbstract
Background: COVID-19 progression affects multiple organ systems, and abnormalities in lipid, liver, and renal function tests have been reported. This study aimed to evaluate changes in organ function and lipid profiles among patients with severe COVID-19 during hospitalization and at discharge.
Methods: A follow-up study was conducted at St. Peter Specialized Hospital from January 1 to April 30, 2021, involving 162 hospitalized COVID-19 patients. Five milliliters of venous blood were collected at admission and again at discharge. Lipid, renal, and liver function tests were performed using the Cobas 311 analyzer. Data were entered and analyzed using SPSS version 25.
Results: Significant mean differences were observed in total cholesterol (20.13 mg/dL; 95% CI: 13.41–26.84; P < 0.001), HDL (7.53 mg/dL; 95% CI: 5.24–9.81; P < 0.001), and LDL (0.10 mg/dL; 95% CI: 0.06–0.14; P < 0.001) between admission and discharge. Albumin levels significantly increased at discharge, while ALT levels significantly decreased (P < 0.05).
Conclusion: Dyslipidemia and hypoalbuminemia were observed during the acute phase of severe COVID-19. These findings suggest that severe COVID-19 induces significant alterations in lipid metabolism and liver function. Monitoring and managing lipid levels may improve clinical outcomes and reduce complications. Integrating lipid management into COVID-19 treatment protocols could enhance patient recovery and care effectiveness.
Downloads
References
Aziz M, Fatima R, Lee-Smith W & Assaly R (2020). The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Critical Care, 24(1):1-4.
Benedetti C, Waldman M, Zaza G, Riella LV & Cravedi P (2020). COVID-19 and the kidneys: an update. Frontiers in medicine, 21(7): 423.doi:10.3389/fmed.2020.00423.
Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, et al. (2020). Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology, 72(5):1864–72
Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, et al. (2021). Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology, 73(3):890–900.
Changaripour S, Sajadi E & Eskandariroozbahani N (2021). A Case-Control Study on Blood Lipid Profile in Patients with COVID-19. Research Square, (https://doi.org/10.21203/rs.3.rs-423471/v2).
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. journal Kidney International, 97(5):829–38.
De la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, et al. (2020). Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. Microorganisms. 8(8):1106.
Fan J (2020). Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. journal of Metabolism: Clinical and Experimental, 107 (https://doi.org/10.1016/j.metabol.2020.154243).
Hu X, Chen D, Wu L, He G & Ye W (2020). Declined serum high-density lipoprotein cholesterol is associated with the severity of COVID-19 infection. International Journal of Clinical Chemistry, 510:105–10.
Hu X, Chen D, Wu L, He G & Ye W (2020). Declined serum high-density lipoprotein cholesterol is associated with the severity of COVID-19 infection. International Journal of Clinical Chemistry, 510:105-10.
Jin H, He J, Dong C, Cao L, Qi X, Huang T, et al. (2020). Altered Lipid Profile is a Risk Factor for the Progression Andrecurrenceof COVID-19: From Two Retrospective Cohorts. Research Square. (https://doi.org/10.21203/rs.3.rs-60159/v1).
Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I & Rela M (2020). COVID-19 and the liver. Journal of Hepatol, 73(5):1231–40.
Khan MMA, Khan MN, Mustagir MG, Rana J, Islam MS & Kabir MI (2020). Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. Journal of Global Health, 10(2):020503.
Kočar E, Režen T & Rozman D (2021). Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1866(2):158849.
Li Y, Zhang Y, Lu R, Dai M, Shen M, Zhang J, et al. (2021). Lipid metabolism changes in patients with severe COVID-19. International Journal of Clinical Chemistry, 517:66-73.
Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al.(2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal (English Edition), 133(9):1032–8.
Lopes GPR, Munhoz MAG & Antonangelo L (2018). Evaluation of the relationship between hematocrit and lipid profile in adults. Jornal Brasileiro de Patologia e Medicina Laboratorial (Brazilian Journal of Pathology and Laboratory Medicine), 54(3):146–52.
Malik J, Ishaq U, Laique T, Ashraf A, Malik A, Rathore MA, et al.(2021). Effect of COVID-19 on Lipid Profile and its Correlation with Acute Phase Reactants. medRxiv. (https://doi.org/10.1101/2021.04.13.21255142):2021.04.13.21255142.
Mohammedsaeed W, Alahamadey Z & Khan M (2020). Alteration of lipid profile in COVID-19 Saudi patients at Al-Madinah Al-Munawarah. Infection. 14:15.
Osuna-Ramos JF, Rendón-Aguilar H, De Jesús-González LA, Reyes-Ruiz JM, Montserrat Espinoza-Ortega A, Antonio Ochoa-Ramírez L, et al. (2020). Serum lipid profile changes and their clinical diagnostic significance in COVID-19 Mexican Patients. medRxiv. 20169789.
Parohan M, Yaghoubi S & Seraji A (2020). Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies. Hepatol Research, 50(8):924–35.
Qin C, Minghan H, Ziwen Z & Yukun L (2020). Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID‐19 pneumonia patients. Food science & nutrition, 8(11):6144-52.
Qin C, Minghan H, Ziwen Z & Yukun L (2020). Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID-19 pneumonia patients. Journal Food Science & Nutrition, 8(11):6144–52.
Sun JT, Chen Z, Nie P, Ge H, Shen L, Yang F, et al. (2020). Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19. Journal Frontiers in Cardiovascular Medicine, 7(1):1–12.
Vancsa S, Hegyi PJ, Zadori N, Szako L, Vörhendi N, Ocskay K, et al. (2020). Pre-existing liver diseases and on-admission liver-related laboratory tests in COVID-19: a prognostic accuracy meta-analysis with systematic review. Frontiers in medicine, 13(7):572115.
Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F, et al. (2020). Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: An observational study. Lipids in Health and Disease, 19(1):1–7.
Wei X, Zeng W, Su J, Wan H, Yu X, Cao X, et al. (2020). Hypolipidemia is associated with the severity of COVID-19. Journal of Clinical Lipidology, 14(3):297-304.
Wu Y, Li H, Guo X, Yoshida EM & Mendez N (2020). Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients : a systematic review and meta-analysis. Hepatol International, 14(5):621–37.
Xiuqi Wei, Wenjuan Zeng, Jingyu Su, Huimin Wan, Xinqin Yu, Xiaoling Cao, et al. (2020). Hypolipidemia is associated with the severity of COVID-19. Journal of Clinical Lipidology. 14 (https://doi.org/10.1016/j.jacl.2020.04.008):297–304.
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. (2020). Clinical findings in a group of patients
infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. British Medical Journal, 19;368.
Zaim S, Chong JH, Sankaranarayanan V & Harky A (2020). COVID-19 and multiorgan response. Current problems in cardiology, 45(8):100618.
Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. (2020). Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical microbiology and infection, 26(6):767-72.
Zhu Z, Fan L, Lou K (2020). A Preliminary Study on Blood Lipid Profile in Patients with COVID-19. Research square, https://doi.org/10.21203/rs.3.rs-57301/v1.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ethiopian Journal of Public Health and Nutrition (EJPHN)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under GNU General public license.